Anika Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2016 | 14.6% | 14.6% | 13.5% |
| FY2017 | 12.1% | 12.1% | 11.3% |
| FY2018 | 7.1% | 7.1% | 6.7% |
| FY2019 | 9.4% | 9.4% | 8.2% |
| FY2020 | -8.8% | -8.8% | -6.6% |
| FY2021 | 1.4% | 1.4% | 1.2% |
| FY2022 | -5.2% | -5.2% | -4.3% |
| FY2023 | -38.9% | -38.9% | -30.5% |
| FY2024 | -36.6% | -36.6% | -27.8% |
| FY2025 | -7.6% | -7.6% | -5.7% |